Oxford Nanopore Technologies Plc (ONT.L) Monday said that it expects to report revenue of around 223 million pounds to 224 million pounds in fiscal 2025, compared to 183.2 million pounds in fiscal 2024, up around 22 percent on a reported basis and 24 percent on a constant currency basis.
On the LSE, ONT.L is currently up 6.4 percent on Monday's trading at 149.80 pence.
The British biotechnology company said that this is slightly ahead of its earlier given guidance range of 20 percent to 23 percent on a constant currency basis. Revenue growth exceeded 20 percent at constant currency across all regions, including EMEAI, APAC and AMR.
Oxford Nanopore Technologies said that across customer-end markets, clinical revenue increased by approximately 60 percent on a reported basis, while BioPharma revenue grew by approximately 30 percent and Applied Industrial revenue by approximately 27 percent. Research revenue also grew by 15 percent, the company added.
Oxford Nanopore Technologies said that it will release the preliminary annual results for fiscal 2025 on Monday, March 2.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.